Author

Luis M Ortega

Hospital Clínico San CarlosORCID 0000-0002-7987-8531Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Carlos Lacalle-GonzáleziD· 1 shared Carlos Lopez-Blazquez· 1 shared Javier Martínez‐UserosiD· 1 shared Jesús García‐FoncillasiD· 1 shared Lara Sanz-CriadoiD· 1 shared María Jesús Fernández‐AceñeroiD· 1 shared Michael Ochieng’ Otieno· 1 shared Miguel Ángel Hidalgo-León· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Carlos Lacalle-GonzálezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

FOLFIRINOX Combined with GPX4 Inhibition Induces Ferroptosis and Defines Redox-Based Therapeutic Subgroups in Pancreatic Cancer

Carlos Lacalle-González, Carlos Lopez-Blazquez, Miguel Ángel Hidalgo-León, Michael Ochieng’ Otieno, Lara Sanz-Criado, María Jesús Fernández‐Aceñero, Luis M Ortega, Jesús García‐Foncillas, Javier Martínez‐Useros

This paper evaluates combining FOLFIRINOX with GPX4 inhibition to induce ferroptosis in pancreatic cancer, identifying redox-based biomarkers for treatment stratification.

bioRxiv · Sep 12, 2025 · PreprintCancer Biology